Skip to main content

Table 4 Factors associated with PTSD symptoms among COVID-19 survivors

From: Post-traumatic stress symptoms among an Egyptian sample of post-remission COVID-19 survivors: prevalence and sociodemographic and clinical correlates

Variable Total IES-R score t P value
No-to-mild symptoms (n = 24) Moderate-to-severe (n = 61)
Age Mean ± SD 34.5 ± 8.5 36.5 ± 9.7 −0.89 0.375
  No % No % χ2  
Gender Female 16 66.7 53 86.9 4.608 0.032
Male 8 33.3 8 13.1
Marital status Married 20 83.3 55 90.2 0.77 0.379
Not married 4 16.7 6 9.8
Residence Rural 15 62.5 40 65.6 0.071 0.790
Urban 9 37.5 21 34.4
Level of education Low to moderate 10 41.7 43 70.5 6.10 0.014
High 14 58.3 18 29.5
Occupation Skilled 21 87.5 56 91.8 1.17 0.558
Employee 3 12.5 4 6.6
Unemployed 0 0.0 1 1.6
Hx of psychiatric illnesses Yes 3 12.5 4 6.6 0.81 0.370
No 21 87.5 57 93.4
Hx of medical illnesses Yes 5 20.8 14 23.0 0.044 0.833
No 19 79.2 47 77.0
Hx of COVID-19 symptom severity Mild 17 70.8 23 37.7 7.59 0.006
Moderate to severe 7 29.2 38 62.3
Medications given during COVID-19 infection Antibiotics 21 95.5 53 94.6 0.02 0.884
Anticoagulants 13 59.1 36 64.3 0.18 0.669
Antimalarial 11 50.0 26 46.4 0.08 0.776
Iverizine 14 63.6 39 69.6 0.26 0.609
Steroids 10 45.5 35 44.9 1.88 0.170
     MWU  
Home isolation (days) Mean ± SD 12.59 ± 10.30 8.56 ± 9.24 −0.91 0.361
Hospital isolation (days)   4.70 ± 6.93 7.25 ± 9.73 −1.04 0.298
HADS scoring
Depression   4.17 ± 2.97 9.72 ± 3.48 −1.41 0.157
Anxiety   4.42 ± 2.98 9.74 ± 3.64 −1.93 0.054
  1. Bold text indicates statistical significance where P value < 0.05